Exchange: PNK Industry: Drug Manufacturers
0.00% $0.0675
America/New_York / 3 mai 2024 @ 12:46
FUNDAMENTALS | |
---|---|
MarketCap: | 1.646 mill |
EPS: | -0.0100 |
P/E: | -6.75 |
Earnings Date: | May 15, 2024 |
SharesOutstanding: | 24.39 mill |
Avg Daily Volume: | 0.0105 mill |
RATING 2024-05-03 |
---|
B- |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Buy | |
P/E: | Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -6.75 | sector: PE -11.58 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -6.75 | industry: PE -6.21 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0.0555 - 0.0795 ( +/- 17.78%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2016-11-07 | Keogh Timothy Ryan | Buy | 5 000 | Common Stock |
2016-11-07 | Keogh Timothy Ryan | Buy | 5 000 | Warrant |
2014-01-17 | Strategic Capital Partners, Llc | Sell | 0 | Common Stock |
2013-03-25 | Keogh Timothy Ryan | Sell | 0 | Common Stock |
2014-01-17 | Barton Benjamin J | Buy | 0 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 4 transactions |
Buy: 10 000 | Sell: 0 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | $0.0675 (0.00% ) |
Volume | 0.0093 mill |
Avg. Vol. | 0.0105 mill |
% of Avg. Vol | 88.31 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
AmeriCann, Inc. operates as a specialized cannabis company in the United States. It designs, develops, leases, and operates cultivation, processing, and manufacturing facilities for licensed cannabis businesses. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52-acre parcel of land located in Freetown, southeastern Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is based in Denver, Colorado.